HSBC Holdings
RMD icon

HSBC Holdings’s ResMed RMD Stock Holding History

HSBC Holdings’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$70.3M Sell
313,511
-15,274
-5% -$3.81M 0.04% 422
2025
Q4 		$79.3M Buy
328,785
+49,253
+18% +$12.6M 0.04% 382
2025
Q3 		$76.5M Buy
279,532
+12,047
+5% +$3.29M 0.04% 389
2025
Q2 		$68.9M Buy
267,485
+2,318
+0.9% +$553K 0.04% 388
2025
Q1 		$59.3M Buy
265,167
+28,786
+12% +$6.72M 0.04% 441
2024
Q4 		$54.1M Sell
236,381
-770
-0.3% -$185K 0.03% 461
2024
Q3 		$57.8M Buy
237,151
+4,619
+2% +$1.03M 0.03% 452
2024
Q2 		$44.6M Sell
232,532
-37,391
-14% -$7.59M 0.03% 482
2024
Q1 		$53.4M Buy
269,923
+58,715
+28% +$10.8M 0.04% 450
2023
Q4 		$36.3M Sell
211,208
-279,006
-57% -$42.9M 0.03% 506
2023
Q3 		$72.8M Buy
490,214
+256,624
+110% +$46.4M 0.08% 275
2023
Q2 		$51.1M Buy
233,590
+19,623
+9% +$4.37M 0.05% 358
2023
Q1 		$46.9M Sell
213,967
-21,405
-9% -$4.64M 0.06% 353
2022
Q4 		$48.9M Buy
235,372
+113,307
+93% +$24.9M 0.06% 348
2022
Q3 		$26.8M Sell
122,065
-8,813
-7% -$2.01M 0.04% 425
2022
Q2 		$27.7M Buy
130,878
+7,790
+6% +$1.66M 0.04% 471
2022
Q1 		$30.2M Sell
123,088
-11,803
-9% -$2.85M 0.04% 471
2021
Q4 		$35.3M Sell
134,891
-32,082
-19% -$8.32M 0.03% 500
2021
Q3 		$44.2M Sell
166,973
-5,428
-3% -$1.48M 0.04% 369
2021
Q2 		$42.5M Sell
172,401
-14,516
-8% -$3.05M 0.05% 381
2021
Q1 		$36M Sell
186,917
-314,287
-63% -$63M 0.04% 413
2020
Q4 		$106M Buy
501,204
+351,668
+235% +$70.1M 0.14% 135
2020
Q3 		$25.8M Buy
149,536
+30,751
+26% +$5.68M 0.04% 394
2020
Q2 		$22.8M Sell
118,785
-5,484
-4% -$897K 0.04% 391
2020
Q1 		$18.6M Buy
124,269
+21,437
+21% +$3.41M 0.04% 391
2019
Q4 		$16.1M Sell
102,832
-18,114
-15% -$2.61M 0.03% 606
2019
Q3 		$16.3M Sell
120,946
-7,277
-6% -$953K 0.03% 618
2019
Q2 		$15.6M Buy
128,223
+1,410
+1% +$156K 0.03% 615
2019
Q1 		$13.2M Sell
126,813
-2,248
-2% -$232K 0.02% 666
2018
Q4 		$14.7M Buy
129,061
+28,515
+28% +$3.06M 0.03% 634
2018
Q3 		$11.6M Sell
100,546
-66
-0.1% -$7.23K 0.02% 786
2018
Q2 		$10.4M Sell
100,612
-70,253
-41% -$7.11M 0.02% 784
2018
Q1 		$16.8M Sell
170,865
-18,901
-10% -$1.79M 0.03% 620
2017
Q4 		$16.1M Sell
189,766
-304,432
-62% -$25.2M 0.02% 560
2017
Q3 		$38M Buy
494,198
+377,377
+323% +$28.9M 0.06% 318
2017
Q2 		$9.1M Sell
116,821
-381,579
-77% -$27.3M 0.02% 787
2017
Q1 		$35.9M Buy
498,400
+377,342
+312% +$26.1M 0.07% 274
2016
Q4 		$7.51M Buy
121,058
+54,957
+83% +$3.37M 0.02% 816
2016
Q3 		$4.28M Sell
66,101
-4,446
-6% -$296K 0.01% 950
2016
Q2 		$4.46M Buy
70,547
+26,686
+61% +$1.57M 0.01% 943
2016
Q1 		$2.54M Sell
43,861
-10,518
-19% -$595K 0.01% 1092
2015
Q4 		$2.92M Sell
54,379
-57,933
-52% -$3.27M 0.01% 1134
2015
Q3 		$5.72M Buy
112,312
+42,971
+62% +$2.31M 0.01% 768
2015
Q2 		$3.91M Buy
69,341
+15,538
+29% +$981K 0.01% 906
2015
Q1 		$3.86M Buy
53,803
+12,134
+29% +$788K 0.01% 995
2014
Q4 		$2.34M Sell
41,669
-946
-2% -$49.4K ﹤0.01% 1121
2014
Q3 		$2.1M Buy
42,615
+4,528
+12% +$231K ﹤0.01% 1147
2014
Q2 		$1.93M Buy
38,087
+4,363
+13% +$216K ﹤0.01% 1143
2014
Q1 		$1.51M Buy
33,724
+6,532
+24% +$293K ﹤0.01% 1139
2013
Q4 		$1.28M Buy
27,192
+4,998
+23% +$253K ﹤0.01% 1216
2013
Q3 		$1.17M Buy
22,194
+12,150
+121% +$589K ﹤0.01% 1205
2013
Q2 		$453K Buy
+10,044
New +$477K ﹤0.01% 1223

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HSBC Holdings's RMD Position: Q1 2026 in Review

HSBC Holdings reduced its ResMed (RMD) stake by 4.6% in Q1 2026, selling an estimated $3.81M and leaving 313,511 shares worth $70.3M. The position accounts for 0.04% of the portfolio, ranked #422.

HSBC Holdings first reported a position in RMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $106M in Q4 2020. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • HSBC Holdings held 313,511 shares of ResMed worth $70.3M as of Q1 2026.
  • HSBC Holdings sold 15,274 ResMed shares in Q1 2026, an estimated $3.81M.
  • ResMed made up 0.04% of HSBC Holdings's portfolio in Q1 2026, its #422 holding.
  • HSBC Holdings first reported a position in ResMed in Q2 2013 and has held it in 52 quarters since.
  • HSBC Holdings's ResMed position peaked at $106M in Q4 2020.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.